CPC A61K 47/20 (2013.01) [A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 33/04 (2013.01); A61K 33/243 (2019.01); A61K 47/02 (2013.01); A61K 47/18 (2013.01); A61K 47/183 (2013.01)] | 26 Claims |
1. A method of reducing ototoxicity in a human patient receiving a platinum based chemotherapeutic for the treatment of cancer sensitive to the platinum based chemotherapeutic comprising administering an effective amount of a pharmaceutical composition comprising aqueous anhydrous sodium thiosulfate, wherein the aqueous anhydrous sodium thiosulfate is at a concentration of about 0.5 M and further comprising about 0.004 M boric acid.
|